MULTI_LOGO_SWRPT.png
Streetwise Reports Examines the Commercial Launch Planned for Schizophrenia Drug
January 24, 2019 07:00 ET | Streetwise Reports Llc
SAN FRANCISCO, Jan. 24, 2019 (GLOBE NEWSWIRE) -- DURECT Corp. (DRRX:NASDAQ), a biopharmaceutical company, noted that Indivior Plc announced that it will launch in the U.S. its drug for the treatment...
MULTI_LOGO_SWRPT.png
Streetwise Reports Examines How One Analyst Says This Biotech Company Could Potentially 'Double'
November 15, 2017 09:00 ET | Streetwise Reports Llc
SAN FRANCISCO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Analyst Grant Zeng of Zacks Small Cap Research examines what transpired with this biopharmaceutical company during Q3/17. Included in this article...